Physician profile
Jesse D Moore
NPI 1750342531
$1,538.63
in general payments reported to CMS, 2019-2025
10 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $71.39 · 2021: $113 · 2022: $285 · 2023: $151 · 2024: $138 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $907.87 | 2019-2025 | Dovato, Cabenuva |
| Abbvie INC. | $199.17 | 2024-2025 | |
| Gilead Sciences, INC. | $137.43 | 2019-2025 | Biktarvy |
| Boston Scientific Corporation | $69.81 | 2022 | |
| Emd Serono, INC. | $63.67 | 2019-2025 | |
| Janssen Biotech, INC. | $49.00 | 2021-2023 | Symtuza |
| Theratechnologies INC. | $39.82 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $27.65 | 2021-2025 | Breztri |
| E.R. Squibb & Sons, L.L.C. | $24.96 | 2025 | Cobenfy |
| Alkermes, INC. | $19.25 | 2023 | Vivitrol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.